Human Muscle-Specific A-Kinase Anchoring Protein (mAKAP) Polymorphisms: Mechanistic Role in Cardiovascular Diseases

Simple item page
dc.contributor.authorSuryavanshi, Santosh
dc.contributor.authorAnderson, Kody
dc.contributor.authorJadhav, Shweta
dc.contributor.authorLichtarge, Olivier
dc.contributor.authorMcConnell, Bradley K.
dc.date.accessioned2018-02-23T19:36:23Z
dc.date.available2018-02-23T19:36:23Z
dc.date.issued2017
dc.description.abstractmAKAP polymorphisms may pre-dispose humans to CVDs by altering cAMP/PKA signaling in the heart. PKA-mAKAP interaction modulators can be developed as therapeutic target to augment current treatment of CVDs. This project was completed with contributions from Alexei Degterev from the Department of Developmental, Molecular and Chemical Biology, School of Medicine, Tufts University, Boston.
dc.description.departmentPharmacological and Pharmaceutical Sciences, Department of
dc.identifier.urihttp://hdl.handle.net/10657/2340
dc.language.isoen_US
dc.titleHuman Muscle-Specific A-Kinase Anchoring Protein (mAKAP) Polymorphisms: Mechanistic Role in Cardiovascular Diseases
dc.typePoster

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Suryavanshi_Santosh_GRaSP2017.pdf
Size:
1.72 MB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.76 KB
Format:
Plain Text
Description:
Download

Collections

GRS 2017